España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
MiNK Therapeutics
INKT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$9.16
2.27
32.95%
At close: -
$8.54
-0.62
-6.77%
After Hours: Jan 31, 7:46 PM EDT
Get Report
Comment
MiNK Therapeutics (INKT) Forecast
News
Earnings
MiNK Therapeutics (INKT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for MiNK Therapeutics (NASDAQ:INKT) Stock
MiNK Therapeutics Stock (NASDAQ: INKT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 29, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, January 28, 2025
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Friday, November 15, 2024
Baird Maintains Outperform on MiNK Therapeuti...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on MiNK Th...
Benzinga Newsdesk
Thursday, November 14, 2024
MiNK Therapeutics Q3 EPS $(0.05) Beats $(0.08...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2024
Benzinga Insights
Wednesday, November 13, 2024
Examining the Future: MiNK Therapeutics's Earnings Outlook
Benzinga Insights
Thursday, November 07, 2024
MiNK's iNKT Cell Therapy Shows Potential For ...
Benzinga Newsdesk
Wednesday, October 09, 2024
HC Wainwright & Co. Reiterates Buy on MiNK Th...
Benzinga Newsdesk
Tuesday, October 08, 2024
MiNK Therapeutics, Autonomous Therapeutics En...
Benzinga Newsdesk
Friday, October 04, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Tuesday, August 13, 2024
HC Wainwright & Co. Reiterates Buy on MiNK Th...
Benzinga Newsdesk
MiNK Therapeutics Q2 2024 GAAP EPS $(0.07) Be...
Benzinga Newsdesk
Wednesday, July 31, 2024
MiNK Therapeutics Announced That It Has Regai...
Benzinga Newsdesk
Wednesday, May 22, 2024
MiNK Presents AgenT-797 Clinical Activity in ...
Benzinga Newsdesk
Tuesday, May 14, 2024
MiNK Therapeutics shares are trading lower. T...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on MiNK Th...
Benzinga Newsdesk
MiNK Therapeutics Q1 2024 GAAP EPS $(0.11) Be...
Benzinga Newsdesk
Monday, May 13, 2024
Why MiNK Therapeutics Stock Is Up 11% Monday
Dylan Berman
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
MiNK Therapeutics shares are trading higher a...
Benzinga Newsdesk
MiNK Therapeutics To Sell Securities In Priva...
Benzinga Newsdesk
Monday, April 08, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
MiNK Therapeutics Announces Preclinical Activ...
Benzinga Newsdesk
Friday, April 05, 2024
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, March 21, 2024
HC Wainwright & Co. Maintains Buy on MiNK The...
Benzinga Newsdesk
MiNK Therapeutics Q4 EPS $(0.16) Misses $(0.1...
Benzinga Newsdesk
Earnings Scheduled For March 21, 2024
Benzinga Insights
Wednesday, March 20, 2024
Earnings Outlook For MiNK Therapeutics
Benzinga Insights
Wednesday, March 06, 2024
MiNK Announces Preclinical Data Showcasing Ac...
Benzinga Newsdesk
Wednesday, February 14, 2024
MiNK Therapeutics, Inc. Announces First Refra...
Benzinga Newsdesk
Wednesday, February 07, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, February 06, 2024
MiNK Therapeutics' AgenT-797 Presents Results...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Tuesday, January 30, 2024
MiNK Therapeutics' MiNK's AgenT-797 Offers Ne...
Benzinga Newsdesk
Wednesday, December 20, 2023
MiNK Therapeutics And ImmunoScape Collaborate...
Benzinga Newsdesk
Thursday, November 09, 2023
MiNK Therapeutics Q3 2023 EPS $(0.15) Beats $...
Benzinga Newsdesk
Earnings Scheduled For November 9, 2023
Benzinga Insights
Friday, November 03, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
MiNK Therapeutics Presents Clinical Activity ...
Benzinga Newsdesk
Tuesday, October 17, 2023
Sacks Parente Golf And 3 Other Stocks Under $2 Insiders Are Buying
Lisa Levin
Monday, October 09, 2023
Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying
Lisa Levin
Wednesday, October 04, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Tuesday, August 29, 2023
MiNK Therapeutics 10% Owner Makes $281K Stock Purchase
Benzinga Insights
Thursday, August 10, 2023
HC Wainwright & Co. Reiterates Buy on MiNK Th...
Benzinga Newsdesk
MiNK Therapeutics Q2 EPS $(0.18) Beats $(0.20...
Benzinga Newsdesk
Earnings Scheduled For August 10, 2023
Benzinga Insights
Thursday, June 22, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Monday, May 22, 2023
MiNK Presents Clinical Data On Allogeneic iNK...
Benzinga Newsdesk
Show More
